Brief: Spectral Ai Hopes To Transition Clinical Studies And Work For DFU Into Commercial Activities In Early 2025
05/02/2024 15:39
Feb 5 (Reuters) - Spectral AI Inc MDAI.O :
* SPECTRAL AI INC - HOPE TO TRANSITION OUR CLINICAL STUDIES
AND
WORK FOR DFU INTO COMMERCIAL ACTIVITIES IN EARLY 2025
* SPECTRAL AI - SUBMITTED FOR REGULATORY APPROVAL IN UK FOR
OUR
DEEPVIEW AI-BURN INDICATION,EXPECT TO BEGIN REVENUE-GENERATING
ACTIVITY IN H2 OF THIS YEAR
Source text for Eikon: ID:n0001213900-24-009894
Further company coverage: MDAI.O
Recent news on Spectral AI
See all newsBrief: Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication
Brief: Spectral Ai Inc - Forecasts Fy2026 Revenue Of About $18.5 Million
Brief: Spectral Ai Names David Mcguire, Cpa, As Chief Financial Officer
Brief: Spectral Ai Names Vincent S. Capone As Chief Executive Officer
Brief: Spectral AI raises $7.6 Million of Additional Growth Capital